Other reports have identified the importance of the PI3K pathway and integrin-VLA-4 signaling in facilitating BTKi resistance or enhanced focal adhesion kinase (FAK) or CXCR4 activity in MCL during MCL–stromal cell interaction [49–51]. Here, PTK2 is linked to mantle cell lymphoma.